USPTO serial 79157046
KASP
Reviewed by CopyMark Law Group
Reg. 5005449Status 739Renewal
- Filing date
- Status date
- Registration date
- Jul 26, 2016
- Examiner
- THOMAS, JULIE
- Law office
- GENERIC WEB UPDATE
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with KASP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,295*
Plus Government fees of $4,250
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Middlesex TW11 0LY, GB
Middlesex TW11 0LY, GB
Middlesex TW11 0LY, GB
GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mainak H. Mehta
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP525 B. Street, Suite 2200San Diego, CA 92101UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry, science, agriculture, horticulture and forestry, agrochemical trials and farming; agrochemicals for use with crops and soil management; reagents for use with agrochemicals; fertilizers; organic chemicals, solvents and agrochemicals for industrial and commercial use; chemicals and chemical products for use in the manufacture of biocides, pesticides, herbicides, fungicides, insecticides and plant growth regulators; soil conditioning preparations for regulating and enhancing the growth of agricultural products and produce; chemical reagents for nonmedical purposes used in genetic analysis processes featuring magnesium chloride (Mg2Cl), DNA polymerase (Taq polymerase), dimethylsulphoxide (DMSO), water, tris-HCl buffer, passive reference dyes (5-carboxy-X-rhodamine succinimidyl ester (ROX)), genomic DNA, dinucleotide triphosphates (dNTPs), unlabeled DNA oligonucleotides, DNA oligonucleotides labelled with fluorescent reporter dyes, and DNA oligonucleotides labelled with quencher dyes for use in research; DNA sequences for use in genotyping; chemical substances for use in crop analysis; chemical substances for use in agricultural chemical technology; reagents for use with agrochemicals for research purposes; chemical substances for use in plant genome testing; chemical substances for analytical and biochemical science, genetic measurements, chemical diagnostics, forensic analysis, DNA testing, analytical molecular biology | ACTIVE | — |
| 005 | Clinical medical diagnostic reagents; reagent preparations for medical or veterinary genetic diagnosis; medical and veterinary diagnostic preparations for testing bodily fluids samples, bodily excretions, tissue samples, cell samples, hair samples, cell and tissue cultures, laboratory cultures, swabs, bacterial, fungal and viral and microbial cultures, whole blood and blood fractions; testing preparations for medical and veterinary diagnostic applications; medicinal and diagnostic preparations and substances for use in medical and diagnostic assays, namely, reagents used in genetic analysis processes featuring magnesium chloride (Mg2Cl), DNA polymerase (Taq polymerase), dimethylsulphoxide (DMSO), water, tris-HCl buffer, passive reference dyes (5-carboxy-X-rhodamine succinimidyl ester (ROX)), genomic DNA, dinucleotide triphosphates (dNTPs), unlabeled DNA oligonucleotides, DNA oligonucleotides labelled with fluorescent reporter dyes, and DNA oligonucleotides labelled with quencher dyes; medical testing and medical diagnostic testing preparations for bodily fluids, bodily samples, bodily excretions, tissue samples, cell samples, hair samples, cell and tissue cultures, laboratory cultures, swabs, bacterial, fungal and viral and microbial cultures, whole blood and blood fractions; medical diagnostic reagent and assays for testing body fluids; diagnostic preparations for medical use; veterinary diagnostic reagents used in genetic analysis processes featuring magnesium chloride (Mg2Cl), DNA polymerase (Taq polymerase), dimethylsulphoxide (DMSO), water, tris-HCl buffer, passive reference dyes (5-carboxy-X-rhodamine succinimidyl ester (ROX)), genomic DNA, dinucleotide triphosphates (dNTPs), unlabeled DNA oligonucleotides, DNA oligonucleotides labelled with fluorescent reporter dyes, and DNA oligonucleotides labelled with quencher dyes | ACTIVE | — |
| 009 | Scientific equipment, apparatus and instruments for scientific, pharmaceutical and medical research purposes, namely, well microtitre plates, plate drying ovens, pipettes and pipette tips, well plate liquid handling and dispensing devices, well plate pressure, heat and laser welding, sealing devices, water bath PCR devices, thermal blocks, Peltier block-based thermocyclers, Peltier block-based isothermal devices, thermocycling and isothermal devices, portable thermocyclers and isothermal devices, FRET-capable microtube and plate readers; scientific equipment, apparatus and instruments for agrochemical technology, namely, well microtitre plates, plate drying ovens, pipettes and pipette tips, well plate liquid handling and dispensing devices, well plate pressure, heat and laser welding, sealing devices, water bath PCR devices, thermal blocks, Peltier block-based thermocyclers, Peltier block-based isothermal devices, thermocycling and isothermal devices, portable thermocyclers and isothermal devices, FRET-capable microtube and plate readers; computer systems comprising hardware and software for collecting, recording, analysing, storing, organising of genetic and molecular data and managing projects; computer software, namely, sequencing-based genotyping computer software; software for crop analysis; software for plant genome testing; laboratory experimental machines and apparatus, namely, well microtitre plates, plate drying ovens, pipettes and pipette tips, well plate liquid handling and dispensing devices, well plate pressure, heat and laser welding, sealing devices, water bath PCR devices, thermal blocks, Peltier block-based thermocyclers, Peltier block-based isothermal devices, thermocycling and isothermal devices, portable thermocyclers and isothermal devices, FRET-capable microtube and plate readers; laboratory apparatus and instruments, namely, well microtitre plates, plate drying ovens, pipettes and pipette tips, well plate liquid handling and dispensing devices, well plate pressure, heat and laser welding, sealing devices, water bath PCR devices, thermal blocks, Peltier block-based thermocyclers, Peltier block-based isothermal devices, thermocycling and isothermal devices, portable thermocyclers and isothermal devices, FRET-capable microtube and plate readers; DNA testing apparatus which carry or hold DNA samples for use in detecting, screening and sequencing such samples not for medical/diagnostic purposes; gene sequencing products, namely, computer-driven probes and substrates for use in gene discovery; computer software for use in database management; biotechnology related software, namely, software for storing and analysing genotyping, sequencing and extraction data; apparatus for crop analysis, namely, well microtitre plates, plate drying ovens, pipettes and pipette tips, well plate liquid handling and dispensing devices, well plate pressure, heat and laser welding, sealing devices, water bath PCR devices, thermal blocks, Peltier block-based thermocyclers, Peltier block-based isothermal devices, thermocycling and isothermal devices, portable thermocyclers and isothermal devices, FRET-capable microtube and plate readers; apparatus for plant genome testing, namely, well microtitre plates, plate drying ovens, pipettes and pipette tips, well plate liquid handling and dispensing devices, well plate pressure, heat and laser welding, sealing devices, water bath PCR devices, thermal blocks, Peltier block-based thermocyclers, Peltier block-based isothermal devices, thermocycling and isothermal devices, portable thermocyclers and isothermal devices, FRET-capable microtube and plate readers; computer systems comprising hardware and software for collecting, storing, analysing and reporting biological information, all the foregoing for use in clinical diagnostic analysis, genotyping, sequencing, and extraction; software for use in data management, data storage, data analysis, report generation, all in the fields of genetics, genetic testing, genetic screening, genotyping, sequencing of DNA, and extraction of DNA | ACTIVE | — |
| 010 | Clinical or medical diagnostic apparatus and instruments, namely, well microtitre plates, plate drying ovens, pipettes and pipette tips, well plate liquid handling and dispensing devices, well plate pressure, heat and laser welding, sealing devices, water bath PCR devices, thermal blocks, Peltier block-based thermocyclers, Peltier block-based isothermal devices, thermocycling and isothermal devices, portable thermocyclers and isothermal devices, FRET-capable microtube and plate readers; apparatus for carrying out medical or diagnostic assays, namely, well microtitre plates, plate drying ovens, pipettes and pipette tips, well plate liquid handling and dispensing devices, well plate pressure, heat and laser welding, sealing devices, water bath PCR devices, thermal blocks, Peltier block-based thermocyclers, Peltier block-based isothermal devices, thermocycling and isothermal devices, portable thermocyclers and isothermal devices, FRET-capable microtube and plate readers; testing devices for medical or diagnostic purposes, namely, well microtitre plates, plate drying ovens, pipettes and pipette tips, well plate liquid handling and dispensing devices, well plate pressure, heat and laser welding, sealing devices, water bath PCR devices, thermal blocks, Peltier block-based thermocyclers, Peltier block-based isothermal devices, thermocycling and isothermal devices, portable thermocyclers and isothermal devices, FRET-capable microtube and plate readers | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research in the field of genetics, genetic testing, genetic screening, genotyping, sequencing and extraction of DNA, agrochemical technology; crop analysis; plant genome testing; design and development of software for use in data management, data storage, data analysis, report generation, all in the fields of genetics, genetic testing, genetic screening, genotyping, sequencing of DNA, and extraction of DNA; database design and development and computer-aided technical diagnostic testing for scientific and research use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LGC Genomics Limited
- Other trademarks owned by LGC Genomics Limited
- Other trademarks owned by LGC Genomics Limited
- Other trademarks owned by LGC Genomics Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named KASP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 5, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 26, 2025 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Feb 23, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Apr 2, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 11, 2023 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Feb 11, 2023 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Feb 2, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 29, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 2, 2022 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Aug 2, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 2, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 26, 2022 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jul 26, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 23, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 25, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 7, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 6, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 26, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 26, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 1, 2016 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 18, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 18, 2016 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 10, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 10, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 20, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 20, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 20, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 5, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 5, 2016 | ALIE | ASSIGNED TO LIE | — |
| Mar 31, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 10, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 9, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 9, 2016 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 13, 2015 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 13, 2015 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 13, 2015 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 19, 2015 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 19, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 16, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 16, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 9, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jun 30, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 30, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 30, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 15, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 31, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 31, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 28, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 27, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 26, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 22, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 22, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 18, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |